A new trial has shown that targeting a blood glucose level of 4.0–7.0 mmol/l in critically ill children has some benefits, including a reduced incidence of kidney failure, shortened duration of hospital stay and lowered health-care costs. However, the chosen short-term primary end point was unaffected, which limits the applicability of the findings.
- Greet Van den Berghe
- Dieter Mesotten
